Blog | Veristat, The Science-First CRO

3 min read

FDA’s Draft Guidance for Data Monitoring Committees (DMCs)

How Veristat’s Proven DMC Expertise for Complex Trials Supports Patient Safety and Sponsor Success

4 min read

Monthly FDA Guidance and Regulatory News Review - July 2024

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

12 min read

Veristat Global Policy Insights Q2

Index:  RECENT DEVELOPMENTS: EU | RECENT DEVELOPMENTS: US | other recent developments | Outlook

Topics in focus

4 min read

Monthly FDA Guidance and Regulatory News Review - June 2024

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

3 min read

FSP/Resourcing: Meeting the Moment with Expert Resources

Clinical trial leaders in small and medium-sized biotech companies regularly find themselves at the intersection of growing requirements, shrinking timelines, and talent shortages. With organizational restructuring and staffing reductions continuing,...

2 min read

Monthly FDA Guidance and Regulatory News Review - May 2024

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

1 min read

Achieve Regulatory Excellence and Accelerate Your Clinical Trials with Veristat

Learn how Veristat’s multidisciplinary team helped sponsors navigate the complexities of global regulatory submissions, achieving early and successful outcomes.

4 min read

Webinar Q&A: How to Advance New Cancer Therapies in Alignment with FDA Project FrontRunner

In partnership with Clinical Leader, Veristat consulting, regulatory, and clinical experts gave a live webinar outlining how to better advance new cancer therapies in alignment with FDA’s Project FrontRunner. The webinar covered the following:

• What is...

5 min read

Monthly FDA Guidance and Regulatory News Review - April 2024

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

1 min read

Harness the FDA's Project FrontRunner to Advance Your New Oncology Therapies

Are you interested in learning about the latest FDA initiative to accelerate the development of new cancer treatments? Veristat's informative webinar "Advancing Development of New Oncology Therapies, aligning with FDA's Project FrontRunner" is an...